Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Molson Coors Beverage Company A | TAP-A | Sep 26, 2024 | 58.26 | 0.00 |
Momentus A | MNTS | Sep 26, 2024 | 0.54 | -2.85 |
Monarch Casino & Resort | MCRI | Sep 26, 2024 | 78.94 | +2.63 |
Monday.com | MNDY | Sep 26, 2024 | 273.09 | -2.71 |
Mondee | MOND | Sep 26, 2024 | 1.41 | -0.70 |
Mondelez International A | MDLZ | Sep 26, 2024 | 74.32 | +0.35 |
Moneyhero | MNY | Sep 26, 2024 | 1.12 | -1.75 |
MoneyLion A | ML | Sep 26, 2024 | 39.14 | -4.68 |
MongoDB A | MDB | Sep 26, 2024 | 272.65 | -2.02 |
Monogram Technologies | MGRM | Sep 26, 2024 | 2.51 | +2.87 |
Monolithic Power Systems | MPWR | Sep 26, 2024 | 944.39 | +3.24 |
Monopar Therapeutics | MNPR | Sep 26, 2024 | 5.84 | +12.96 |
Monro | MNRO | Sep 26, 2024 | 28.76 | +2.31 |
Monroe Capital | MRCC | Sep 26, 2024 | 7.93 | -1.25 |
Monster Beverage | MNST | Sep 26, 2024 | 52.01 | +0.66 |
Montana Technologies A | AIRJ | Sep 26, 2024 | 5.98 | +0.84 |
Montauk Renewables | MNTK | Sep 26, 2024 | 5.07 | +3.89 |
Monte Rosa Therapeutics | GLUE | Sep 26, 2024 | 5.36 | -2.72 |
Montrose Environmental Group | MEG | Sep 26, 2024 | 27.53 | -1.82 |
Moodys | MCO | Sep 26, 2024 | 474.03 | -0.45 |
Moog A | MOG-A | Sep 26, 2024 | 199.28 | -0.03 |
Moog B | MOG-B | Sep 26, 2024 | 198.29 | 0.00 |
Moolec Science | MLEC | Sep 26, 2024 | 0.82 | -2.60 |
MoonLake Immunotherapeutics | MLTX | Sep 26, 2024 | 51.37 | +1.10 |
Morgan Stanley | MS | Sep 26, 2024 | 104.60 | +2.21 |
Morgan Stanley China A Share Fund | CAF | Sep 26, 2024 | 12.87 | +7.07 |
Morgan Stanley Direct Lending Fund | MSDL | Sep 26, 2024 | 19.88 | -0.20 |
Morgan Stanley Emerging Markets Debt Fund | MSD | Sep 26, 2024 | 8.11 | +0.50 |
Morgan Stanley Emerging Markets Domestic Debt Fund | EDD | Sep 26, 2024 | 5.16 | 0.00 |
Morgan Stanley FXDFR Pref | MS-K | Sep 26, 2024 | 25.50 | -0.39 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.